BACKGROUND AND OBJECTIVES: A kidney disease of unknown cause is common in Sri Lanka's lowland (dry) region. Detailed clinical characterizations of patients with biopsy-proven disease are limited, and there is no current consensus on criteria for a noninvasive diagnosis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We designed a prospective study in a major Sri Lankan hospital servicing endemic areas to ascertain pathologic and clinical characteristics of and assess risk factors for primary tubulointerstitial kidney disease. We used logistic regression to determine whether common clinical characteristics could be used to predict the presence of primary tubulointerstitial kidney disease on kidney biopsy. RESULTS: From 600 new patients presenting to a tertiary nephrology clinic over the course of 1 year, 87 underwent kidney biopsy, and 43 (49%) had a biopsy diagnosis of primary tubulointerstitial kidney disease. On detailed biopsy review, 13 (30%) had evidence of moderate to severe active kidney disease, and six (15%) had evidence of moderate to severe chronic tubulointerstitial kidney disease. Patients with tubulointerstitial kidney disease were exclusively born in endemic provinces; 91% spent a majority of their lifespan there. They were more likely men and farmers (risk ratio, 2.0; 95% confidence interval, 1.2 to 2.9), and they were more likely to have used tobacco (risk ratio, 1.7; 95% confidence interval, 1.0 to 2.3) and well water (risk ratio, 1.5; 95% confidence interval, 1.1 to 2.0). Three clinical characteristics-age, urine dipstick for protein, and serum albumin-could predict likelihood of tubulointerstitial kidney disease on biopsy (model sensitivity of 79% and specificity of 84%). Patients referred for kidney biopsy despite comorbid diabetes or hypertension did not experience lower odds of tubulointerstitial kidney disease. CONCLUSIONS: A primary tubulointerstitial kidney disease occurs commonly in specific regions of Sri Lanka with characteristic environmental and lifestyle exposures.
BACKGROUND AND OBJECTIVES: A kidney disease of unknown cause is common in Sri Lanka's lowland (dry) region. Detailed clinical characterizations of patients with biopsy-proven disease are limited, and there is no current consensus on criteria for a noninvasive diagnosis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We designed a prospective study in a major Sri Lankan hospital servicing endemic areas to ascertain pathologic and clinical characteristics of and assess risk factors for primary tubulointerstitial kidney disease. We used logistic regression to determine whether common clinical characteristics could be used to predict the presence of primary tubulointerstitial kidney disease on kidney biopsy. RESULTS: From 600 new patients presenting to a tertiary nephrology clinic over the course of 1 year, 87 underwent kidney biopsy, and 43 (49%) had a biopsy diagnosis of primary tubulointerstitial kidney disease. On detailed biopsy review, 13 (30%) had evidence of moderate to severe active kidney disease, and six (15%) had evidence of moderate to severe chronic tubulointerstitial kidney disease. Patients with tubulointerstitial kidney disease were exclusively born in endemic provinces; 91% spent a majority of their lifespan there. They were more likely men and farmers (risk ratio, 2.0; 95% confidence interval, 1.2 to 2.9), and they were more likely to have used tobacco (risk ratio, 1.7; 95% confidence interval, 1.0 to 2.3) and well water (risk ratio, 1.5; 95% confidence interval, 1.1 to 2.0). Three clinical characteristics-age, urine dipstick for protein, and serum albumin-could predict likelihood of tubulointerstitial kidney disease on biopsy (model sensitivity of 79% and specificity of 84%). Patients referred for kidney biopsy despite comorbid diabetes or hypertension did not experience lower odds of tubulointerstitial kidney disease. CONCLUSIONS: A primary tubulointerstitial kidney disease occurs commonly in specific regions of Sri Lanka with characteristic environmental and lifestyle exposures.
Authors: Rebecca L Laws; Daniel R Brooks; Juan José Amador; Daniel E Weiner; James S Kaufman; Oriana Ramírez-Rubio; Alejandro Riefkohl; Madeleine K Scammell; Damaris López-Pilarte; José Marcel Sánchez; Chirag R Parikh; Michael D McClean Journal: Int J Occup Environ Health Date: 2015-01-28
Authors: Shanika Nanayakkara; Toshiyuki Komiya; Neelakanthi Ratnatunga; S T M L D Senevirathna; Kouji H Harada; Toshiaki Hitomi; Glenda Gobe; Eri Muso; Tilak Abeysekera; Akio Koizumi Journal: Environ Health Prev Med Date: 2011-10-13 Impact factor: 3.674
Authors: Zeid Badurdeen; Nishantha Nanayakkara; Neelakanthi V I Ratnatunga; Abdul W M Wazil; Tilak D J Abeysekera; Premil N Rajakrishna; Jalitha P Thinnarachchi; Ranjith Kumarasiri; Dulani D Welagedera; Needika Rajapaksha; Adambarage P D Alwis Journal: Clin Nephrol Date: 2016 Supplement 1 Impact factor: 0.975
Authors: Jennifer Hoponick Redmon; Myles F Elledge; Donna S Womack; Rajitha Wickremashinghe; Kamani P Wanigasuriya; Roshini J Peiris-John; Joseph Lunyera; Kristin Smith; James H Raymer; Keith E Levine Journal: BMC Nephrol Date: 2014-07-28 Impact factor: 2.388
Authors: Susan R Mendley; Adeera Levin; Ricardo Correa-Rotter; Bonnie R Joubert; Elizabeth A Whelan; Brian Curwin; Erik H Koritzinsky; Denise M Gaughan; Paul L Kimmel; Shuchi Anand; Pedro Ordunez; Ludovic Reveiz; Diane S Rohlman; Madeleine K Scammell; Robert O Wright; Robert A Star Journal: Kidney Int Date: 2019-08-02 Impact factor: 10.612
Authors: Shakila Premarathne; Rohana Chandrajith; Nishantha Nanayakkara; C D Gamage; Neelakanthi Ratnatunga; Sulochana Wijetunge; Zeid Badurdeen; Shashika Guruge; N Elladeniya; K P S Madushan; K O C U Samarasiri; Pasan Hewavitharane; Dulanjali Herath; Sachintha Senarathne Journal: Biol Trace Elem Res Date: 2021-08-25 Impact factor: 3.738
Authors: Thilini W Hettiarachchi; Buddhi N T W Fernando; Thilini Sudeshika; Zeid Badurdeen; Shuchi Anand; Ajith Kularatne; Sulochana Wijetunge; Hemalika T K Abeysundara; Nishantha Nanayakkara Journal: PLoS One Date: 2021-04-14 Impact factor: 3.752
Authors: Jennifer Pett; Fahim Mohamed; John Knight; Christine Linhart; Nicholas J Osborne; Richard Taylor Journal: Nephrology (Carlton) Date: 2021-11-09 Impact factor: 2.358